Takeda Pharmaceutical (TAK) AI Analysis

TAK$21.41—
Drug Manufacturers - Specialty & GenericLarge CapGrowth Stock
Compare
Market cap$69.55BEnterprise value—Revenue (TTM)—Market positionTop 25%

Score

53
Neutral
Value
53
Quality
47
Growth
60

Takeda Pharmaceutical is a mixed profile at 53/100 — Value 53, Growth 60, Quality 47. Under the hood: P/E 28.5, about 20% below its own multi-year median, plus revenue compounding ~4% annually over recent years.

Takeda Pharmaceutical (TAK) AI Analysis

TAK price $21.41 —

Ticker
TAK
Price
$21.41
Change
—
Market cap
$69.55B
P/E
28.48
Dividend yield
2.90%
Beta
0.09
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
53
Value
53
Quality
47
Growth
60

Stocklytics score rationale: value 53, quality 47, growth 60.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener